People

Jakob E. Larsen
Jakob E. Larsen joined DeepLife’s Advisory Board in September2026. The issuer says he spent fifteenyears at NovoNordisk leading target-discovery efforts and brings global pharmaceuticalR&D and strategic experience, advancing earlydiscovery through innovative science and digital approaches. His advisorywork supportsDeepLife TwinCell causal-cellmodels, targetidentification and indicationexpansion. The nativeannouncement explicitly says formerNovoNordisklead; it does not assertcurrentemploymentthere, exactservice dates or personalinvestment.
Roles
DeepLife
CurrentAdvisory Board Member